Incyte (INCY) FCF Margin (2010 - 2026)

Incyte (INCY) posted FCF Margin of 28.89% for Q1 2026, down 24.33% on a QoQ basis from 38.18% in Q4 2025, and up 390.0% year-over-year from 5.9% in Q1 2025.

Incyte (INCY) FCF Margin (2010 - 2026) Analysis & Trends

Incyte's FCF Margin history runs 17 years deep, the most recent figure standing at 28.89% for Q1 2026.

  • Quarterly FCF Margin rose 390.0% year-over-year to 28.89% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28.22% (up 2157.0% YoY) and the FY2025 annual result came in at 27.4%, up 2152.0% from the prior year.
  • FCF Margin was 28.89% for Q1 2026 at Incyte, down from 38.18% in the prior quarter.
  • Across five years, FCF Margin topped out at 38.54% in Q3 2025 and bottomed at 55.18% in Q2 2024.
  • A 5-year average of 18.79% and a median of 25.32% in 2024 frame the typical range for FCF Margin.
  • Annual changes were most pronounced in 2024 — FCF Margin plunged 8715 bps — and 2025, when it soared 5877 bps.
  • Incyte's FCF Margin stood at 31.19% in 2022, then plunged by 45 bps to 17.06% in 2023, then soared by 48 bps to 25.32% in 2024, then jumped by 51 bps to 38.18% in 2025, then dropped by 24 bps to 28.89% in 2026.
  • Business Quant data shows INCY's FCF Margin at 28.89% in Q1 2026, 38.18% in Q4 2025, and 38.54% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 28.89%

Historic Data

Download Data
DateValue
Mar 31, 2026 28.89%
Dec 31, 2025 38.18%
Sep 30, 2025 38.54%
Jun 30, 2025 3.59%
Mar 31, 2025 25.00%
Dec 31, 2024 25.32%
Sep 30, 2024 27.08%
Jun 30, 2024 -55.18%
Mar 31, 2024 24.80%
Dec 31, 2023 17.06%
Sep 30, 2023 13.28%
Jun 30, 2023 31.97%
Mar 31, 2023 -13.44%
Dec 31, 2022 31.19%
Sep 30, 2022 36.01%
Jun 30, 2022 19.86%
Mar 31, 2022 27.27%
Dec 31, 2021 9.37%
Sep 30, 2021 17.14%
Jun 30, 2021 26.95%